Discount Agreement for Rivaroxaban Medications
AOK Niedersachsen offers non-exclusive discount agreements for Rivaroxaban (except 2.5 mg) until exclusive contracts take effect. This allows all interested pharmaceutical companies to participate in the 'open-house model' until 31.08.2028 at the latest.
CONTRACTING AUTHORITY
Name
AOK Niedersachsen. Die Gesundheitskasse.
City
Hannover
Country
DE
CLASSIFICATION
Procedure Type
Open Procedure
Contract Type
Supplies
Main CPV
33600000, Pharmaceutical products.
ADDITIONAL DETAILS
EU Funded
Yes
Electronic Submission
not-allowed
Legal Basis
32014L0024
DEADLINES & TIMELINE
Submission Deadline
726 days remaining(LOT-0000)
Published